Company profile ONCT
After 39 days of this quarter the interest is at 205.0. Based on that we can calculate that during remaining 52 days it will total up to 478.0. Oncternal Therapeutics expected interest is significantly higher compared to previous quarter (+658.7%) and same quarter last year (+158.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 236 | 245 3.8% QoQ | 224 -8.6% QoQ | 88 -60.7% QoQ |
| 2020 | 178 -24.6% YoY 102.3% QoQ | 133 -45.7% YoY -25.3% QoQ | 73 -67.4% YoY -45.1% QoQ | 306 247.7% YoY 319.2% QoQ |
| 2021 | 258 44.9% YoY -15.7% QoQ | 302 127.1% YoY 17.1% QoQ | 164 124.7% YoY -45.7% QoQ | 110 -64.1% YoY -32.9% QoQ |
| 2022 | 199 -22.9% YoY 80.9% QoQ | 149 -50.7% YoY -25.1% QoQ | 116 -29.3% YoY -22.1% QoQ | 87 -20.9% YoY -25.0% QoQ |
| 2023 | 185 -7.0% YoY 112.6% QoQ | 153 2.7% YoY -17.3% QoQ | 97 -16.4% YoY -36.6% QoQ | 63 -27.6% YoY -35.1% QoQ |
| 2024 | 205 10.8% YoY 225.4% QoQ | - | - | - |
The average 5 years interest of Oncternal Therapeutics was 13.68 per week. The last year interest of Oncternal Therapeutics compared to the last 5 years has changed by -7.53%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -28.41%.
After 39 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 52 days it will total up to 58.0. Oncternal Therapeutics stock expected interest is significantly higher compared to same quarter last year (+52.6%) but lower than previous quarter (-76.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 31 | 169 445.2% QoQ | 135 -20.1% QoQ | 84 -37.8% QoQ |
| 2020 | 72 132.3% YoY -14.3% QoQ | 67 -60.4% YoY -6.9% QoQ | 67 -50.4% YoY 0.0% QoQ | 140 66.7% YoY 109.0% QoQ |
| 2021 | 197 173.6% YoY 40.7% QoQ | 90 34.3% YoY -54.3% QoQ | 261 289.6% YoY 190.0% QoQ | 111 -20.7% YoY -57.5% QoQ |
| 2022 | 90 -54.3% YoY -18.9% QoQ | 57 -36.7% YoY -36.7% QoQ | 28 -89.3% YoY -50.9% QoQ | 127 14.4% YoY 353.6% QoQ |
| 2023 | 38 -57.8% YoY -70.1% QoQ | 116 103.5% YoY 205.3% QoQ | 94 235.7% YoY -19.0% QoQ | 250 96.9% YoY 166.0% QoQ |
| 2024 | 25 -34.2% YoY -90.0% QoQ | - | - | - |
The average 5 years interest of Oncternal Therapeutics stock was 8.62 per week. The last year interest of Oncternal Therapeutics stock compared to the last 5 years has changed by 8.24%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 4.6%.
There is not enough data for Oncternal Therapeutics news to provide analysis
There is not enough data for Oncternal Therapeutics news to provide correlation calculation
There is not enough data for Oncternal Therapeutics news to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. zilovertamab expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 23 | 19 -17.4% QoQ | 37 94.7% QoQ | 41 10.8% QoQ |
| 2020 | 109 373.9% YoY 165.9% QoQ | 31 63.2% YoY -71.6% QoQ | 25 -32.4% YoY -19.4% QoQ | 108 163.4% YoY 332.0% QoQ |
| 2021 | 52 -52.3% YoY -51.9% QoQ | 25 -19.4% YoY -51.9% QoQ | 105 320.0% YoY 320.0% QoQ | 206 90.7% YoY 96.2% QoQ |
| 2022 | 70 34.6% YoY -66.0% QoQ | 93 272.0% YoY 32.9% QoQ | 68 -35.2% YoY -26.9% QoQ | 72 -65.0% YoY 5.9% QoQ |
| 2023 | 39 -44.3% YoY -45.8% QoQ | 165 77.4% YoY 323.1% QoQ | 105 54.4% YoY -36.4% QoQ | 131 81.9% YoY 24.8% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of zilovertamab was 5.84 per week. The last year interest of zilovertamab compared to the last 5 years has changed by 32.02%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 117.8%.
There is not enough data for ONCT-216 to provide analysis
There is not enough data for ONCT-216 to provide correlation calculation
There is not enough data for ONCT-216 to provide analysis
There is not enough data for ONCT-808 to provide analysis
There is not enough data for ONCT-808 to provide correlation calculation
There is not enough data for ONCT-808 to provide analysis
There is not enough data for ONCT-534 to provide analysis
There is not enough data for ONCT-534 to provide correlation calculation
There is not enough data for ONCT-534 to provide analysis
There is not enough data for Oncternal Therapeutics clinical trials to provide analysis
There is not enough data for Oncternal Therapeutics clinical trials to provide correlation calculation
There is not enough data for Oncternal Therapeutics clinical trials to provide analysis
There is not enough data for Oncternal Therapeutics pipeline. to provide analysis
There is not enough data for Oncternal Therapeutics pipeline. to provide correlation calculation
There is not enough data for Oncternal Therapeutics pipeline. to provide analysis